Advertisement
Research Article Free access | 10.1172/JCI115734
Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Find articles by Postigo, A. in: JCI | PubMed | Google Scholar
Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Find articles by Garcia-Vicuña, R. in: JCI | PubMed | Google Scholar
Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Find articles by Diaz-Gonzalez, F. in: JCI | PubMed | Google Scholar
Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Find articles by Arroyo, A. in: JCI | PubMed | Google Scholar
Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Find articles by De Landázuri, M. in: JCI | PubMed | Google Scholar
Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Find articles by Chi-Rosso, G. in: JCI | PubMed | Google Scholar
Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Find articles by Lobb, R. in: JCI | PubMed | Google Scholar
Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Find articles by Laffon, A. in: JCI | PubMed | Google Scholar
Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Spain.
Find articles by Sánchez-Madrid, F. in: JCI | PubMed | Google Scholar
Published May 1, 1992 - More info
The infiltration of the synovial membrane (SM) by mononuclear cells, mostly T cells, is a typical histopathological feature associated with rheumatoid arthritis (RA). The entry of T lymphocytes into the SM is believed to be mediated by a number of molecules in the endothelium that are induced in response to a series of inflammatory mediators. In this study, we have investigated the adhesion of synovial T cells from RA patients to two endothelial ligands: endothelial-leukocyte adhesion molecule-1 (ELAM-1), the only selectin known to function as a vascular addressin for T cells, and vascular cell adhesion molecule-1 (VCAM-1), the cellular ligand of VLA-4. Our results clearly demonstrate that synovial T cells isolated from both SM and synovial fluid (SF), bearing an activated and memory phenotype, displayed an enhanced capacity to interact with these two endothelial molecules as compared with T cells from peripheral blood (PB) either of the same RA patients or healthy donors. A further enhancement of VLA-4-mediated T cell binding to VCAM-1 and fibronectin could be observed when already in vivo-activated synovial T cells were stimulated in vitro with phorbol esters, suggesting the existence of several cellular affinity levels for both very late activation-4 (VLA-4) ligands. Moreover, both PB and synovial T cells from RA patients exhibited strong proliferative responses when they were cultured with either fibronectin or VCAM-1 in combination with submitogenic doses of anti-CD3 mAb. This increased endothelial binding ability of synovial T lymphocytes together with their proliferation in response to the interaction with VCAM-1 and fibronectin may represent important mechanisms in the regulation of T cell penetration and persistence in the chronically inflamed SM of RA.
Images.